Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

289
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
289

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Competing-triggering effect models for multitype recurrent event data.

Biometrics·2026
Same author

Risk-Based Prophylactic Human Papillomavirus Vaccination of Heterosexual US Men Aged 27 to 45 Years for Prevention of Oropharyngeal Cancer.

The Journal of infectious diseases·2026
Same author

Validation of Methylated DNA Markers for Esophageal Squamous Cancer: An International Study.

Cancer prevention research (Philadelphia, Pa.)·2026
Same author

Drinking water nitrate, disinfection byproducts, and prostate cancer incidence in the Agricultural Health Study.

Journal of the National Cancer Institute·2025
Same author

Computer-aided detection for esophageal achalasia (with video).

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society·2025
Same author

International, Multicenter Analysis of Endoscopic Full-Thickness Resection of Duodenal Neuroendocrine Tumors.

The American journal of gastroenterology·2025
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Nov 7, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.4K

Is group testing ready for prime-time in disease identification?

Gregory Haber1, Yaakov Malinovsky2, Paul S Albert1

  • 1Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.

Statistics in Medicine
|April 29, 2021
PubMed
Summary
This summary is machine-generated.

Group testing for infectious disease screening can reduce costs, but accuracy concerns persist. This study reveals that flawed assumptions about assay accuracy can significantly hinder the effectiveness and feasibility of group testing in medical settings.

Keywords:
disease screeningepidemiologygroup testingmeasurement error

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.2K
Author Spotlight: Accelerating Diagnostic Accuracy with Direct Identification of Gram-Negatives from Blood Culture Bottles
09:07

Author Spotlight: Accelerating Diagnostic Accuracy with Direct Identification of Gram-Negatives from Blood Culture Bottles

Published on: May 24, 2024

1.2K

Related Experiment Videos

Last Updated: Nov 7, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.4K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.2K
Author Spotlight: Accelerating Diagnostic Accuracy with Direct Identification of Gram-Negatives from Blood Culture Bottles
09:07

Author Spotlight: Accelerating Diagnostic Accuracy with Direct Identification of Gram-Negatives from Blood Culture Bottles

Published on: May 24, 2024

1.2K

Area of Science:

  • Public Health
  • Biostatistics
  • Infectious Disease

Background:

  • Large-scale disease screening balances cost and public health needs.
  • Group testing, pooling samples to reduce tests, is appealing for infectious disease screening.
  • Skepticism exists regarding group testing's impact on assay accuracy.

Purpose of the Study:

  • To investigate the impact of inaccurate assumptions on group testing efficacy.
  • To determine the feasibility of group testing for medical screening.
  • To analyze how misclassification parameter assumptions affect sensitivity and test counts.

Main Methods:

  • Explored the consequences of incorrect sensitivity function assumptions in group testing designs.
  • Analyzed the impact of group size on misclassification parameters.
  • Evaluated sample size requirements for validation studies of pooled assays.

Main Results:

  • Incorrect assumptions about sensitivity functions lead to poor estimation of overall sensitivity and expected tests.
  • The impact of group size on misclassification parameters is significant and often overlooked.
  • Validation studies require prohibitively large sample sizes to accurately estimate pooled misclassification parameters.

Conclusions:

  • Current group testing designs may be infeasible for medical screening due to questionable assumptions.
  • Accurate estimation of misclassification parameters, considering group size, is critical for effective group testing.
  • The large sample sizes needed for validation limit the practical application of group testing.